|
Subunit: Interacts with CCND1 and GRAP2. May also interact with COPS5, RPLP0, SIRT6, SYF2 and TCF3 Developmental stage: Expression may increase during differentiation Sequence caution: Sequence=AAD11777.1; Type=Frameshift; Positions=8, 14, 18; Sequence=AAP97163.1; Type=Frameshift; Positions=17, 40; 1 PDB 3D structure from [IMAGE] and Proteopedia [IMAGE] for CCNDBP1: 3AY5 (3D) [IMAGE]
Tissue specificity: Ubiquitously expressed. Expression is down-regulated in a variety of tumor types including breast, colon, prostate and rectal tumors, and is up-regulated in certain hepatic carcinomas [IMAGE] Custom PCR Arrays for CCNDBP1 Primer Products: [IMAGE] OriGene
Function: UniProtKB/Swiss-Prot Summary: CCDB1_HUMAN, O95273 Function: May negatively regulate cell cycle progression. May act at least in part via inhibition of the cyclin-D1/CDK4 complex, thereby preventing phosphorylation of RB1 and blocking E2F-dependent transcription
Similarity: Belongs to the CCNDBP1 family [IMAGE]
|